Latest news
DDL
Iconovo is proud to sponsor DDL this year again. We see DDL as the most important meeting for inhaled drug delivery in Europe and we are looking forward…
Iconovo has a new granted patent
The Swedish Patent and Registration Office, PRV, has granted Iconovo's first ICOone patent. This is a key milestone showing that Iconovo's inhalers are…
Press releases
Nov 28, 2019, 18:30
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
Nov 28, 2019, 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Nov 19, 2019, 15:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 19, 2019, 15:09
News
IR
English
Corporate Information
Other Corporate Information
Nov 08, 2019, 10:51
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 05, 2019, 09:48
News
IR
English
Corporate Information
Other Corporate Information
Nov 05, 2019, 09:48
News
IR
Swedish
Corporate Information
Other Corporate Information
Oct 25, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Oct 25, 2019, 08:15
News
IR
English
Corporate Information
Other Corporate Information
Oct 25, 2019, 08:15
News
IR
Swedish
Corporate Information
Other Corporate Information
Aug 16, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jul 10, 2019, 14:23
News
IR
Swedish
Corporate Information
Other Corporate Information
May 15, 2019, 19:26
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Raport bolagsstämman
May 03, 2019, 16:26
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 25, 2019, 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Apr 18, 2019, 09:20
News
IR
Swedish
Corporate Information
Other Corporate Information
Apr 15, 2019, 09:21
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Mar 29, 2019, 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 19, 2019, 21:17
News
IR
Swedish
Corporate Information
Other Corporate Information
Mar 19, 2019, 21:09
News
IR
Swedish
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
CEO
Anders Månsson
Mail: anders.mansson@iconovo.se
Press releases
Follow us on Linkedin
